Trial Profile
Vascular Responses of Neointimal Formation and Malapposition after EES (Everolimus-Eluting Stent) Implantation using OCT
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- 18 May 2018 New trial record